InsidersTradesSigma
Track the RYMAN HEALTHCARE LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the authority of ASX. Market capitalisation: €2.1bn. The latest transaction was reported on 1 July 2026 (Change in Substantial Holding). Every trade is free.
Analysts rate RYMAN HEALTHCARE LIMITED Strong Buy (bullish), based on 4 analysts. Average price target: NZ$2.94.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
RYMAN HEALTHCARE LIMITED 是一家在澳大利亚证券交易所上市的公司，专注于医疗保健领域。该公司主要提供老年人住房和护理服务。